NDC properties for "TOLAZamide 250 MG Oral Tablet" (RxCUI 198292)
About this data
The tables show NDC propoerties for TOLAZamide 250 MG Oral Tablet with the RxCUI 198292
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for TOLAZamide 250 MG Oral Tablet (RxCUI 198292)
| MMSL_CODE | BD2922 |
|---|---|
| MMSL_CODE | CD2922 |
| RxCUI | 198292 |
| SNOMEDCT | 325258004 |
| SPL_SET_ID | f82dcff5-4afa-45d8-bc8c-f0f7c0c96272 |
| VUID | 4002365 |
| Prescribable Synonym | TOLAZamide 250 MG Oral Tablet |
| RXNAV_STR | TOLAZamide 250 MG Oral Tablet |
| RxNorm Name | tolazamide 250 MG Oral Tablet |
| Tallman Synonym | TOLAZamide 250 MG Oral Tablet |
| Related queries | Interactions (for RxCUI 198292) |
NDC Properties
NDC Item 00378021701
| NDC 9 | 0378-0217 |
|---|---|
| NDC 10 | 0378-0217-01 |
| NDC Item | 00378021701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0217-01) |
| ANDA | ANDA070259 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 385950 |
| Imprint code | MYLAN;217;250 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-03-31 |
| Marketing effective time low | 2013-01-18 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0217 |
NDC Item 68084055611
| NDC 9 | 68084-556 |
|---|---|
| NDC 10 | 68084-556-11 |
| NDC Item | 68084055611 |
| ANDA | ANDA070259 |
| COLORTEXT | white(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 157905 |
| Imprint code | MYLAN;217;250 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-05-31 |
| Marketing effective time low | 2012-02-13 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 68084-556 |
NDC Item 68084055621
| NDC 9 | 68084-556 |
|---|---|
| NDC 10 | 68084-556-21 |
| NDC Item | 68084055621 |
| Packaging | 3 BLISTER PACK in 1 CARTON (68084-556-21) / 10 TABLET in 1 BLISTER PACK (68084-556-11) |
| ANDA | ANDA070259 |
| COLORTEXT | white(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 157905 |
| Imprint code | MYLAN;217;250 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-05-31 |
| Marketing effective time low | 2012-02-13 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 68084-556 |
NDC Item 00378021701
| NDC 9 | 0378-0217 |
|---|---|
| NDC 10 | 0378-0217-01 |
| NDC Item | 00378021701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0217-01) |
| ANDA | ANDA070259 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 385950 |
| Imprint code | MYLAN;217;250 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-03-31 |
| Marketing effective time low | 2013-01-18 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0217 |
NDC Item 68084055611
| NDC 9 | 68084-556 |
|---|---|
| NDC 10 | 68084-556-11 |
| NDC Item | 68084055611 |
| ANDA | ANDA070259 |
| COLORTEXT | white(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 157905 |
| Imprint code | MYLAN;217;250 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-05-31 |
| Marketing effective time low | 2012-02-13 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 68084-556 |
NDC Item 68084055621
| NDC 9 | 68084-556 |
|---|---|
| NDC 10 | 68084-556-21 |
| NDC Item | 68084055621 |
| Packaging | 3 BLISTER PACK in 1 CARTON (68084-556-21) / 10 TABLET in 1 BLISTER PACK (68084-556-11) |
| ANDA | ANDA070259 |
| COLORTEXT | white(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 157905 |
| Imprint code | MYLAN;217;250 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-05-31 |
| Marketing effective time low | 2012-02-13 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 68084-556 |
NDC Item 00378021701
| NDC 9 | 0378-0217 |
|---|---|
| NDC 10 | 0378-0217-01 |
| NDC Item | 00378021701 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0217-01) |
| ANDA | ANDA070259 |
| COLORTEXT | WHITE(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 385950 |
| Imprint code | MYLAN;217;250 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-03-31 |
| Marketing effective time low | 2013-01-18 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-0217 |
NDC Item 68084055611
| NDC 9 | 68084-556 |
|---|---|
| NDC 10 | 68084-556-11 |
| NDC Item | 68084055611 |
| ANDA | ANDA070259 |
| COLORTEXT | white(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 157905 |
| Imprint code | MYLAN;217;250 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-05-31 |
| Marketing effective time low | 2012-02-13 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 68084-556 |
NDC Item 68084055621
| NDC 9 | 68084-556 |
|---|---|
| NDC 10 | 68084-556-21 |
| NDC Item | 68084055621 |
| Packaging | 3 BLISTER PACK in 1 CARTON (68084-556-21) / 10 TABLET in 1 BLISTER PACK (68084-556-11) |
| ANDA | ANDA070259 |
| COLORTEXT | white(white to off-white) |
| Color | C48325 __ |
| FDA SPL set id | 157905 |
| Imprint code | MYLAN;217;250 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-05-31 |
| Marketing effective time low | 2012-02-13 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 68084-556 |